All Products
  • Antibodies
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
抗体药类似物
Path：Home > Products > Antibodies > 抗体药类似物
Products
Products
Research Grade Eftilagimod Alfa
All
  • Catalog： TD-HM824016
  • Clonality：
  • Application： Research Grade Biosimilar
  • Synonyms： IMP-321,IMP321,LAG-3Ig,LAG3-Ig,hLAG-3-Ig,hLAG-3Ig,sLAG-3-Ig,CAS:1800476-36-1
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Eftilagimod Alfa

Catalog No. TD-HM824016
Species reactivity Human
Applications Research Grade Biosimilar
Isotype Fusion - [LAG3 (lymphocyte activating 3, lymphocyte-activation 3, CD223)]2 - IGHG1 Fc (Fragment constant)
Expression system Mammalian Cells
Target MHC II
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names IMP-321,IMP321,LAG-3Ig,LAG3-Ig,hLAG-3-Ig,hLAG-3Ig,sLAG-3-Ig,CAS:1800476-36-1
Background Eftilagimod alfa (IMP321) is a recombinant LAG-3Ig fusion protein that binds to MHC class II. Eftilagimod alfa mediates antigen-presenting cell (APC) activation followed by CD8 T-cell activation. Eftilagimod alfa can be used for metastatic melanoma and metastatic breast carcinoma research.
Note For research use only. Not for use in clinical or therapeutic applications.